Conference abstract
Innovations in drug delivery technology: Improvements in long-term herpes treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Herpesviruses are ubiquitous pathogens that infect many different animal species worldwide. The human herpesviruses HSV- 1, HSV-2, and VZV are of particular clinical importance because of their frequency and the debilitating sequalae associated with their uncontrolled recurrences. Current antiviral interventions consist of multiple oral daily doses of drugs such as acyclovir (ACV), valacyclovir, or famciclovir; these frequent dosings keep adequately suppressive levels of drug in the tissues to abrogate recrudescence, yet require strict patient compliance. Such adherence to the dosing regimen is required because only 10-20% of ACV is absorbed from the gut and the drug itself has only a 3 hour half-life in vivo; any variance in administration could result in drug troughs that permit virus replication, which could result in the spontaneous appearance of drug-resistant mutants. Previous research in our lab established that ACV can be delivered with near zero-order kinetics from a non-biodegradable silicone implant. The resulting device is also capable of suppressing HSV-1 reactivations in a mouse model over ten weeks. Our current research explores the development of bioerodable drug delivery devices, using polycaprolactone (PCL) as the matrix material. Furthermore, we herein report a novel fabrication method, VASE (volatile acid-solvent evaporation), that most likely results in a molecularly homogeneous mix of polymer and drug and, more significantly, improves stability, longevity, and drug delivery characteristics from the matrix. We expect that VASE will prove to be an important method for more perfect drug dispersion in delivery matrices for other acid-stable drugs in the future.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Barry J Margulies”
- BylineArticles whose byline prints “Jill K Badin”
